Synergy Healthcare

What Synergy Healthcare does

Synergy Healthcare LLC is a privately held, Florida-based clinical research center founded in 2017 and headquartered in Bradenton, with additional clinics in Brandon and St. Petersburg. The company operates as a multi-therapeutic-area research site running clinical trials for sponsors and CROs across NAFLD/NASH, diabetes, hypertension, heart disease, COPD, COVID-19, and ulcerative colitis, while also functioning as a community-facing liver-health platform.

Its core technology stack centers on FDA-approved FibroScan transient elastography for non-invasive liver fibrosis and steatosis assessment, layered with a Metabolic Health Initiative (MHI) and a dedicated Liver Health Center sub-brand that deliver free screenings, lab work, physician exams, and counseling. These programs act as a patient acquisition funnel feeding study enrollment, complemented by a Provider Referral Program that supplies physician practices with the personnel, processes, and technology to run research in-office, plus a $20 Amazon gift-card Refer-a-Friend patient incentive program.

Synergy makes money through professional-services revenue from conducting clinical trials on behalf of pharmaceutical companies, CROs, and sponsors, and through Provider Partnership Services that monetize its site-management infrastructure. Go-to-market is sales-led and event-driven, combining direct CRO/sponsor engagement, physician referral partnerships, recurring free community liver-screening events across Florida, and content/social marketing around metabolic and liver-health topics. The company is small (43 employees) with no disclosed funding, revenue, or institutional ownership.

Name

Synergy Healthcare

Legal name

Synergy Healthcare LLC

Website

https://synergyhealthcorp.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Synergy Healthcare is a Bradenton, Florida-based clinical research center that runs multi-therapeutic-area trials (notably NAFLD/NASH, diabetes, and hypertension) for CROs and sponsors, using FibroScan diagnostics, community screening events, and provider referral partnerships to drive patient enrollment.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

akta.pro secondary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Clinical research services
• Clinical trial site network
• Metabolic disease trials
• Fibroscan liver diagnostics
• NASH NAFLD research

Headquarters

HQ city

Bradenton

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Clinical Research Trial Operations: Synergy Healthcare generates revenue by conducting clinical trials for pharmaceutical companies, CROs, and sponsors. They enroll ideal patients faster, reducing time for metrics like 'first patient, first visit' and 'first patient randomized.'
2. Provider Partnership Services: Revenue generated by providing infrastructure for physician practices to conduct clinical research, enabling practices to become research sites with Synergy's processes, technology, and personnel.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Synergy Healthcare is a clinical research site organization that conducts pharmaceutical and CRO-sponsored clinical trials in metabolic and cardiovascular diseases (NAFLD/NASH, diabetes, hypertension, COPD, heart disease, COVID-19, ulcerative colitis). It supplements trial operations with FDA-cleared FibroScan diagnostic testing, a free Metabolic Health Initiative screening program, and a Liver Health Center offering diagnosis, education, and treatment access. The company also partners with physician practices to enable in-office clinical research infrastructure.

Product overview

Synergy Healthcare is a clinical research center offering a portfolio of healthcare services centered on clinical trials, diagnostic testing, and patient education. The core offering is Clinical Research Trials covering multiple therapeutic areas (NASH, diabetes, heart disease, COVID-19, ulcerative colitis, hypertension, COPD). Supporting services include Fibroscan Diagnostic Testing (a non-invasive liver assessment tool), the Metabolic Health Initiative (a free screening and education program), and the Liver Health Center. The company also operates provider and patient referral programs. The organization is not structured as a platform-plus-modules architecture but rather as a unified clinical research services provider with complementary diagnostic and educational offerings.

Differentiator

Problem solved

Functional benefit

Brands

• Metabolic Health Initiative (MHI): Program focused on increasing awareness of NASH caused by fat accumulation in the liver, providing free screenings and education
• Liver Health Center

Products and services

• Clinical Research Trials Conducts clinical research trials investigating innovative therapies and interventions across NASH, diabetes, heart disease, COPD, COVID-19, ulcerative colitis, and hypertension. All trials are conducted by board-certified physicians and nurses in Bradenton and St Petersburg, FL. Targeted at patients with qualifying conditions and sponsored by CROs and pharmaceutical companies.
• FibroScan Diagnostic Testing FDA-cleared transient elastography (FibroScan) — a non-invasive diagnostic ultrasound-based device used to measure liver scarring (fibrosis) and fatty changes caused by liver diseases. Provides a painless, quick outpatient alternative to traditional liver biopsy. Available to patients (including free via Metabolic Health Initiative) and used in clinical trial screening.
• Metabolic Health Initiative (MHI) An educational and screening program focused on increasing awareness of NASH (nonalcoholic steatohepatitis) and fatty liver disease. Provides free physician exams, laboratory evaluations, free FibroScans, and educational counseling to area participants to promote liver and metabolic health. Targeted at Florida adults at risk for metabolic conditions.
• Liver Health Center A specialized center within Synergy Healthcare dedicated to increasing awareness of Fatty Liver Disease and NASH, which can lead to liver failure. Services include diagnosis, education, and promotion of targeted treatments including potential treatment through clinical trials. Targeted at patients with or at risk for liver disease in Florida.
• Provider Referral Program A program enabling physician practices to conduct clinical research in their offices using Synergy Healthcare's personnel, processes, and technology. Connects patients with trusted specialists and healthcare facilities tailored to their specific needs. Targeted at independent physician practices and community providers in Florida.
• Refer a Friend Program A patient referral program where existing participants can refer friends or family members to join research studies. Referrers receive a $20 Amazon gift card when the referred person enrolls. Targeted at current patients and prospective clinical trial participants in Florida.

Quantifiable outcome

• Free FibroScan diagnostic testing to measure liver scarring without surgery
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Four partnerships are on record, tiered minor.

• Fatty Liver FoundationminorOthersNon-profit patient organization dedicated to supporting Americans with fatty liver, NAFLD, or NASH through awareness, screenings, education, and patient outreach. Synergy Healthcare displays their logo on their website as a partner organization.
• NASH CouncilminorOthersOrganization focused on NASH (nonalcoholic steatohepatitis) awareness and education. Their logo appears on Synergy Healthcare's website indicating partnership or collaboration.
• DDA (DDA appears to be a local organization)minorOthersDDA hosted a free liver screening event at their location: 876 S. Parsons Ave, Brandon FL 33511 on November 12th, 2025.
• PHC Health CareminorOthersPHC Health Care hosted a free liver screening event at their location: 1839 Central Ave, St. Petersburg, FL 33713 on November 21st, 2025.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Celerion: Celerion is a CRO specializing in early-stage clinical pharmacology and metabolic disease studies. It competes with Synergy in the metabolic/NASH clinical trial services space with broader capabilities.
• Clinvest Research: Clinvest Research is a clinical trial site network operating in multiple therapeutic areas, including metabolic conditions. It serves the same CRO and sponsor customer base as Synergy.
• Velocity Clinical Research: Velocity operates one of the largest integrated clinical research site networks in the U.S., conducting trials across multiple therapeutic areas including metabolic disease. It directly competes with Synergy for sponsor contracts and patient enrollment.
• Avacare Clinical Research Network: Avacare is a multi-site clinical research organization conducting trials across therapeutic areas. It is comparable as a clinical research site provider targeting similar CRO and sponsor customers.
• ProSciento: ProSciento is a clinical research organization focused on metabolic disease clinical trials including NASH, diabetes, and obesity. Like Synergy, it specializes in metabolic and NAFLD/NASH trial execution, making it a direct functional peer.

Broad incumbents

• IQVIA: IQVIA is a global clinical research services and technology company that operates site networks and manages trials at scale. It competes for sponsor business across all therapeutic areas including metabolic disease.
• PPD (Thermo Fisher Scientific): PPD, acquired by Thermo Fisher, is a global CRO providing clinical research services across all phases and therapeutic areas. It represents the large-scale incumbent alternative to independent site networks like Synergy.
• Labcorp Drug Development (now Fortrea): Fortrea (spun off from Labcorp) is a global CRO offering end-to-end clinical development services. It is a broader incumbent that competes for the same sponsor contracts Synergy depends on, but at much larger scale.

Others

• Labcorp (Diagnostics): Labcorp is a national diagnostics laboratory partner to Synergy for NASH/Fatty Liver testing. While not a direct competitor, the partnership makes it adjacent to Synergy's diagnostic offering.

Regional players

• Florida Research Associates: Florida Research Associates is a regional clinical research site in Florida conducting multi-specialty trials. As a same-geography peer, it competes directly with Synergy for local patient enrollment and sponsor site selections.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/SynergyHealthCareLLC
• LinkedInlinkedin.com/company/synergy-healthcare-corp
• Instagraminstagram.com/synergy_healthcorp

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synergy Healthcare